It is therefore not surprising that PARP-1 is involved in diseases sharing inflammatory/immune-mediated pathways, such as arthritis, diabetes, neurodegenerative disorders, colitis, and others, some of which are also linked to cancer development [32,44,45,46,95]. Here, PARP1 is linked to cancer.